STEMXPAND
LIVE

Serial Number

79114549

Owner

CELLPROTHERA

Attorney

Jonathan Myers

Filing Date

May 7, 2012

Add to watchlist:

No watchlists yet
View on USPTO

STEMXPAND Trademark

Serial Number: 79114549 • Registration: 4362771

STEMXPAND is a trademark filed by CELLPROTHERA on May 7, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CELLPROTHERA (10 trademarks)

12 rue du Parc
68100 Mulhouse - , FR

Entity Type: 99

Trademark Details

Filing Date

May 7, 2012

Registration Date

July 9, 2013

Published for Opposition

April 23, 2013

Cancellation Date

May 8, 2022

Goods & Services

Biological preparations intended for use in cell cultures; Cell culture media for cultivating stem cells; Growth media for cell growth, namely, culture media for cultivating stem cells intended for medical biotechnology; Biological reagents for molecular biology, chemical reagents for medical use for biological methods; Growth media adapted for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; Cellular function activating agents, namely, cell growth factors and hematopoietic factors; Medicated serums, namely, human serums for cell culture; Antibodies, namely, monoclonal antibodies for the selection and purification of stem cells; All of the aforementioned goods being for medical use

Medical care and treatment; Medical services, namely, cell collection, isolation and growth services for medical purposes; Medical analysis in connection with the treatment of individuals, namely, in vitro diagnostic, testing and statistic analysis of the patient status for medical purposes; Therapeutic treatments

Medical apparatus and instruments for use in cellular therapy, medical apparatus for cell cultivation, medical instruments for cell cultivation, medical apparatus and devices intended for cell separation techniques

Research and development of new products in the field of biotechnology, scientific analysis for medical purposes and the development of new products for medical research for thirds parties

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 26, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 26, 2022 DETH
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 31, 2022 CORN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 24, 2022 LIMN
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 4, 2022 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Jul 3, 2022 LIMG
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 29, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 29, 2022 DETH
REFUSAL PROCESSED BY IB
Dec 25, 2021 RFNT
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 28, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 4, 2020 INTS
INVALIDATION PROCESSED
Nov 3, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 14, 2020 INTR
CANCELLED SECTION 71
Feb 14, 2020 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Feb 6, 2020 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 22, 2019 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Aug 1, 2019 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 9, 2018 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 2, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 10, 2013 FICS
FINAL DISPOSITION PROCESSED
Oct 10, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 9, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Jun 22, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2013 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 19, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2013 CRFA
ASSIGNED TO LIE
Mar 4, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2013 TROA
REFUSAL PROCESSED BY IB
Sep 23, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 5, 2012 RFCS
REFUSAL PROCESSED BY MPU
Sep 4, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 31, 2012 RFCR
NON-FINAL ACTION WRITTEN
Aug 30, 2012 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2012 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 24, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 19, 2012 REPR